Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.63 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 4/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
| ▸ | PBK | Q96KB5 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 1/20 | 0.38 |
| ▸ | FNTB | P49356 | 1/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30685095 | 0.78 | DPP9 (1.00) | DPP8DPP9 | |
| SCHEMBL27356247 | 0.78 | DPP9 (1.00) | DPP8DPP9 | |
| SCHEMBL2637894 | 0.72 | FAAH (0.51) | DPP8DPP9MEN1KMT2APGR | |
| SCHEMBL27356238 | 0.71 | DPP9 (0.77) | DPP8DPP9 | |
| SCHEMBL1937671 | 0.70 | NPC1 (0.84) | NPC1RAB9AMEN1KMT2AEPHX2 | |
| SCHEMBL27357819 | 0.70 | DPP9 (0.81) | DPP8DPP9 | |
| SCHEMBL3374604 | 0.70 | JAK2 (0.51) | DPP8DPP9RAB9AEPHX2PBK | |
| SCHEMBL31284345 | 0.68 | CTSB (0.58) | DPP8DPP9MEN1KMT2AGAA | |
| SCHEMBL8785064 | 0.68 | NPC1 (0.55) | NPC1RAB9AMEN1KMT2AEPHX2 | |
| SCHEMBL26240809 | 0.68 | DPP8 (0.50) | DPP8DPP9PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353833-A1 | DPP9 BINDING COMPOUNDS | UNIV ANTWERPEN (BE) | 2025-11-20 | — | — | US | disclosed |
| WO-2023233024-A1 | DPP9 BINDING COMPOUNDS | UNIVERSITEIT ANTWERPEN (BE) | 2023-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353833-A1 | DPP9 BINDING COMPOUNDS | DPP9, DPP7, DPP3 | DPP8 5/4885DPP9 1/4885NPC1 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.